Trust Point Inc’s AbbVie ABBV Stock Holding History

Trust Point Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.55M	Buy	10,133 +1,780	+21%	+$383K	0.22%	57
2026 Q1	$1.82M	Buy	8,353 +1,363	+19%	+$302K	0.16%	74
2025 Q4	$1.6M	Buy	6,990 +59	+0.9%	+$13.4K	0.13%	78
2025 Q3	$1.6M	Sell	6,931 -582	-8%	-$119K	0.13%	78
2025 Q2	$1.39M	Sell	7,513 -268	-3%	-$49.8K	0.13%	83
2025 Q1	$1.63M	Sell	7,781 -2,713	-26%	-$527K	0.15%	74
2024 Q4	$1.86M	Sell	10,494 -1,241	-11%	-$228K	0.13%	78
2024 Q3	$2.32M	Buy	11,735 +1,760	+18%	+$328K	0.17%	62
2024 Q2	$1.71M	Sell	9,975 -483	-5%	-$80K	0.14%	73
2024 Q1	$1.9M	Buy	10,458 +904	+9%	+$156K	0.15%	72
2023 Q4	$1.48M	Buy	+9,554	New	+$1.39M	0.12%	91

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Trust Point Inc's ABBV Position: Q2 2026 in Review

Trust Point Inc increased its AbbVie (ABBV) stake by 21% in Q2 2026, buying an estimated $383K and bringing the position to 10,133 shares worth $2.55M. The position accounts for 0.22% of the portfolio, ranked #57.

Trust Point Inc first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Trust Point Inc held 10,133 shares of AbbVie worth $2.55M as of Q2 2026.
Trust Point Inc bought 1,780 AbbVie shares in Q2 2026, an estimated $383K.
AbbVie made up 0.22% of Trust Point Inc's portfolio in Q2 2026, its #57 holding.
Trust Point Inc first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.